Shai Novik Overview

  • Company
  • Cryptalgo

  • Primary Position
  • Vice Chairman

  • Primary Industry
  • Healthcare

  • Active Board Seats
  • 2

Shai Novik General Information

Biography

Mr. Shai Novik serves as Vice Chairman at Cryptalgo. He serves as Executive Chairman of the Board at Enlivex Therapeutics. He founded PROLOR Biotech in 2005, and has served as its President until 2014. PROLOR Biotech was listed on NYSE in 2010 and then acquired by OPKO Health in 2013 for $560 million, the largest biotech acquisition in the history of Israeli biotech. Mr. Novik previously served as Chief Operating Officer and Head of Strategic Planning of THCG, Inc., a technology and life sciences investment company. THCG was a portfolio company of Greenwich Street Partners, one of the largest U.S. private equity funds. THCG's own portfolio included several life sciences and medical devices companies. Mr. Novik received his M.B.A, with distinction, from the Cornell University.

Contact Information

Primary Position
Vice Chairman, Cryptalgo
Education
Cornell University, MBA (Master of Business Administration)
Gender
Male
Email
sh
Phone
+41 041
Address
  • Bahnhofstrasse 7
  • 6300 Zug
  • Switzerland
+41 041

Shai Novik Board Seats (2)

Company Industry Ownership Status Financing Status Location Since
Cryptalgo Financial Software Privately Held (no backing) Corporation Zug, Switzerland
Enlivex Therapeutics Drug Discovery Publicly Held Formerly PE-Backed Jerusalem, Israel

Shai Novik Lead Partner on Deals (1)

Shai Novik has been the lead partner on 1 deal. Their latest deal was with BioBlast Pharma, a biotechnology company. The deal was made on 26-Mar-2019.

Company Deal Date Deal Type Deal Size Deal Status Industry Location
BioBlast Pharma 26-Mar-2019 Merger/Acquisition Completed Biotechnology Tel Aviv, Israel

Shai Novik Network (21)

Board Members (15)

Name Company Representing Location From
Baruch Halpert Enlivex Therapeutics Self Jerusalem, Israel
Andrew Singer Enlivex Therapeutics Self Jerusalem, Israel
Enlivex Therapeutics Self Jerusalem, Israel
Enlivex Therapeutics Self Jerusalem, Israel
Enlivex Therapeutics Korea Investment Partners Jerusalem, Israel

Portfolio Executives (6)

Name Company Role Deal date Location
Marlene Haffner MD BioBlast Pharma Director 26-Mar-2019 Tel Aviv, Israel
Gili Cohen BioBlast Pharma Director 26-Mar-2019 Tel Aviv, Israel
BioBlast Pharma Co-Founder, Director and Chief Financial Officer 26-Mar-2019 Tel Aviv, Israel
BioBlast Pharma Chief Medical Officer 26-Mar-2019 Tel Aviv, Israel

Shai Novik FAQs

  • Who is Shai Novik?

    Mr. Shai Novik serves as Vice Chairman at Cryptalgo.

  • How much does Shai Novik typically invest?

    Shai Novik's median deal size is .

  • What is Shai Novik’s main position?

    Shai Novik’s primary position is Vice Chairman.

  • What are the contact details for Shai Novik?

    Shai Novik’s email address is sh and his phone number is +41 041 .

  • How many active board seats does Shai Novik hold?

    Shai Novik holds 2 board seats including Cryptalgo and Enlivex Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »